Psychopharm Flashcards
Atomoxetine s/e
GI, weight loss
Headache, dizziness, fatigue, irritability
Priapism, suicidal thinking, mood changes
Pre-clozapine workup
CBC
Chem-7
LFTs
HbA1C and Lipid profile
ECG if >40 or risk factors
Weight and vital signs
Pancreatic profile
Prolactin
CK and ESR?
Pre-lithium workup
CBC
Chem-10
TSH
Weight and vital signs
HbA1C and lipid profile
b-hCG
ECG if >40 or risk factors
Pre-Epival workup (5ish)
CBC
LFTs
HbA1C and lipid profile
Weight and vital signs
b-hCG
Meds with no baseline workup
Antidepressants?
Lamotrigine
Benzos
Mirtazapine mechanism of action
incr. NE/5HT release via decreased inhibition (blockade of central presynaptic a2 receptors on NE and 5HT2 neurons)
5HT2/3 and H1 antagonist (similar MoA as Mianserin, which is used in Europe)
Trazodone mechanism of action
Weak SRI
5HT2A/a1>H1 antagonist
TCAs - the secondary amines
Nortriptyline
Desipramine
MAOI safety issues
Serotonin syndrome (wait 2 weeks)
Hypertensive crisis (drug-food or drug-drug intxn)
Overdose (only phenelzine, tranylcypromine and isocarboxazid)
Moclobemide mechanism of action
Reversible inhibitor of MAO-A (RIMA)
Predictors of good lithium response in mania (7)
FHx of lithium response or BAD
Mania-Depr-Euthymia course
No SUD or psychosis or neurological deficits
Minimal comorbidity
Few past episodes
Classic, euphoric mania
Previous lithium response
Predictors of good Epival response in mania (6)
Mixed features
Rapid cycling
Multiple previous episodes
Secondary mania
Head trauma
SUD
Predictors of good AAP response in mania (4)
Mixed features
Rapid cycling
Young age
Agitation
Psychopharm Tx of FTD
NOT AChEI
Trazodone (irritability)
Paroxetine (SSRI in general for impulsivity)
Psychopharm Tx of LBD
Rivastigmine (decrease BPSD including hallucinations)
Avoid antipsychotics, but if must, quetiapine or clozapine
Psychopharm for Parkinson’s dementia
If no response to AChEI or quetiapine, try clozapine (gold standard)
Psychopharm for vascular dementia
No evidence for AChEI, but if must, try Donepezil or Reminyl (galantamine)
DGV
Psychopharm for Alzheimer’s
AChEI for mild-mod (donepezil, rivastigmine, galantamine)
Memantine (Ebixa) for mod-sev
Adequate trial of clozapine (3)
At least 8, preferably 12 weeks
Dose at least 400mg/d
Trough levels at least 1100 nmol/L (DIE dosing)
5HT precursor
Tryptophan
Dopamine precursors (2)
Phenylalanine
Tyrosine
Rate-limiting enzyme in 5HT synthesis
Tryptophan hydroxylase
Rate-limiting enzyme in DA synthesis
Tyrosine hydroxylase
Carbamazepine adverse reactions (7)
Rare aplastic anemia
Rare agranulocytosis
Rare SJS/TEN (esp. Asian if HLA-B*1502)
Liver and heart toxicity
SIADH/hyponatremia
Decreased OCP efficacy
Pharm Tx of Serotonin syndrome (3)
Cyproheptadine (5HT antagonist)
Dantrolene
BZD
Pharm Tx ish of NMS (5)
Bromocriptine (DA agonist)
Dantrolene (muscle relaxant)
Amantadine
BZD
ECT
Foods to avoid while on MAOIs
Aged or fermented cheese
Aged or cured meats
Overripe or spoiled foods
Fermented foods
Beer
1A2 substrates (5)
Agomelatine
Clozapine
Duloxetine
Olanzapine
Warfarin
2C19 substrates (3)
Diazepam
Propranolol
Warfarin
2D6 substrates (7)
Abilify
Olanzapine
Risperidone
Tamoxifen
TCAs
Vortioxetine
Venlafaxine (to Pristiq)
3A4 substrates (9)
Abilify
Haldol
Levomilnacipran
Lurasidone
Methadone
Mirtazapine
Quetiapine
Risperidone
Vilazodone
Preferred pharmacoTx in HIV + MDD (2)
Celexa
Cipralex
Preferred pharmacoTx in MDD with anxious distress
GAD treatments (Level 4)
No diff between SSRI/SNRI/Bupropion
Preferred pharmacoTx in MDD with catatonia
BZD
Preferred pharmacoTx in MDD with atypical features
Old studies: MAOI > TCA
Preferred pharmacoTx in MDD with mixed features (2)
Lurasidone (level 2)
Ziprasidone (level 3)
Preferred pharmacoTx in MDD with cognitive dysfunction (3)
Vortioxetine (level 1)
Bupropion, duloxetine, SSRI (level 2)
Moclobemide (level 3)
Preferred pharmacoTx in MDD with sleep problems (4)
Agomelatine (level 1)
Mirtazapine, quetiapine, Trazodone (level 2)